Emergence of ST15 Klebsiella pneumoniae Clinical Isolates Producing Plasmids-Mediated RmtF and OXA-232 in China

References

• Daikos GL, Sophia T, Tzouvelekis LS, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother. 2014;58(4):2322–2328. doi:10.1128/AAC.02166-1324514083
   PubMed Web of Science ®Google Scholar
• Yu F, Dan Y, Pan J. High prevalence of plasmid-mediated 16S rRNA methylase gene rmtB among Escherichia coli clinical isolates from a Chinese teaching hospital. BMC Infect Dis. 2010;10.20082697
   PubMed Web of Science ®Google Scholar
• Galimand M, Courvalin P, Lambert T. RmtF, a new member of the aminoglycoside resistance 16S rRNA N7 G1405 methyltransferase family. Antimicrob Agents Chemother. 2012;56(7):3960–3962. doi:10.1128/AAC.00660-1222547620
   PubMed Web of Science ®Google Scholar
• Hidalgo L, Hopkins KL, Gutierrez B, et al. Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in enterobacteriaceae isolated in India and the UK. J Antimicrob Chemother. 2013;68(7):1543–1550. doi:10.1093/jac/dkt07823580560
   PubMed Web of Science ®Google Scholar
• Lee CS, Vasoo S, Hu F, Patel R, Doi Y. Klebsiella pneumoniae ST147 coproducing NDM-7 carbapenemase and RmtF 16S rRNA methyltransferase in Minnesota. J Clin Microbiol. 2014;52(11):4109–4110. doi:10.1128/JCM.01404-1425143576
   PubMed Web of Science ®Google Scholar
• Mancini S, Poirel L, Tritten ML, Lienhard R, Bassi C, Nordmann P. Emergence of an MDR Klebsiella pneumoniae ST231 producing OXA-232 and RmtF in Switzerland. J Antimicrob Chemother. 2017. doi:10.1093/jac/dkx428
   Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 29th Ed. CLSI Supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2019.
   Google Scholar
• Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123. doi:10.1016/j.diagmicrobio.2010.12.00221398074
   PubMed Web of Science ®Google Scholar
• Berçot B, Poirel L, Nordmann P. Updated multiplex polymerase chain reaction for detection of 16S rRNA methylases: high prevalence among NDM-1 producers. Diagn Microbiol Infect Dis. 2011;71(4):442–445. doi:10.1016/j.diagmicrobio.2011.08.01622000158
   PubMed Web of Science ®Google Scholar
• Pitout JDD, Peirano G, Kock MM, Strydom K-A, Matsumura Y. The global ascendency of OXA-48-type carbapenemases. Clin Microbiol Rev. 2019;33(1):e00102–00119. doi:10.1128/CMR.00102-1931722889
   PubMed Web of Science ®Google Scholar
• Peirano G, Ahmed-Bentley J, Fuller J, Rubin JE, Pitout JDD. Travel-related carbapenemase-producing gram-negative bacteria in Alberta, Canada: the first 3 years. J Clin Microbiol. 2014;52(5):1575–1581. doi:10.1128/JCM.00162-1424599977
   PubMed Web of Science ®Google Scholar
• Kim SY, Ko KS. Diverse plasmids harboring blaCTX-M-15 in Klebsiella pneumoniae ST11 isolates from several Asian countries. Microb Drug Resist. 2019;25(2):227–232. doi:10.1089/mdr.2018.002030212274
   PubMed Web of Science ®Google Scholar
• Potron A, Rondinaud E, Poirel L, et al. Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from enterobacteriaceae. Int J Antimicrob Agents. 2013;41(4):325–329. doi:10.1016/j.ijantimicag.2012.11.00723305656
   PubMed Web of Science ®Google Scholar
• Stoesser N, Giess A, Batty EM, et al. Genome sequencing of an extended series of NDM-producing Klebsiella pneumoniae isolates from neonatal infections in a Nepali hospital characterizes the extent of community- versus hospital-associated transmission in an endemic setting. Antimicrob Agents Chemother. 2014;58(12):7347–7357. doi:10.1128/aac.03900-1425267672
   PubMed Web of Science ®Google Scholar
• Nahid F, Zahra R, Sandegren L, Chang Y-F. A blaOXA-181-harbouring multi-resistant ST147 Klebsiella pneumoniae isolate from Pakistan that represent an intermediate stage towards pan-drug resistance. PLoS One. 2017;12(12):e0189438. doi:10.1371/journal.pone.018943829220374
   PubMed Web of Science ®Google Scholar
• Yin D, Dong D, Li K, et al. Clonal dissemination of OXA-232 carbapenemase-producing Klebsiella pneumoniae in neonates. Antimicrob Agents Chemother. 2017;61(8). doi:10.1128/AAC.00385-17
   Web of Science ®Google Scholar
• Shu L, Dong N, Lu J, et al. Emergence of OXA-232 carbapenemase-producing Klebsiella pneumoniae that carries a pLVPK-like virulence plasmid among elderly patients in China. Antimicrob Agents Chemother. 2019;63(3). doi:10.1128/aac.02246-18
   Web of Science ®Google Scholar
• Partridge SR. Analysis of antibiotic resistance regions in gram-negative bacteria. FEMS Microbiol Rev. 2011 35(5):1574–6976.
   Web of Science ®Google Scholar
• Johnson TJ, Nolan LK. Pathogenomics of the virulence plasmids of Escherichia coli. Microbiol Mol Biol Rev. 2010;74(3):477–478. doi:10.1128/MMBR.00002-10
   Web of Science ®Google Scholar
• Taylor E, Sriskandan S, Woodford N, Hopkins KL. High prevalence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacteriaceae in the UK and Ireland. Int J Antimicrob Agents. 2018;52(2):278–282. doi:10.1016/j.ijantimicag.2018.03.01629596903
   PubMed Web of Science ®Google Scholar
• Abdul Momin MHF, Liakopoulos A, Phee LM, Wareham DW. Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei Darussalam. J Glob Antimicrob Resist. 2017 S2213716517300516.
   Google Scholar
• Li X, Ma W, Qin Q, et al. Nosocomial spread of OXA-232-producing Klebsiella pneumoniae ST15 in a teaching hospital, Shanghai, China. BMC Microbiol. 2019;19(1):235. doi:10.1186/s12866-019-1609-131660869
   PubMed Web of Science ®Google Scholar